Statin News and Research

RSS

Statins are drugs used to lower cholesterol. Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries, narrowing or even blocking them.

New drug that cuts risk of cardiovascular disease shows promise

The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein (LDL) cholesterol by as much as 40 percent.

18 Dec 2007

Statins taken after stroke may increase risk of hemorrhagic stroke

People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke.

13 Dec 2007

Simple two-in-one test signals high risk after a heart attack

Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal.

4 Dec 2007

Discovery of gene responsible for statin-induced muscle pain

Statins, the popular class of drugs used to lower cholesterol, are among the most commonly prescribed medications in developed countries.

27 Nov 2007

Patient knowledge of heart risk profile may help improve cholesterol management

Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.

27 Nov 2007

Communication key to tackling cardiovascular disease

Despite the increasing evidence that managing high cholesterol reduces cardiovascular events, many people do not achieve recommended lipid levels.

27 Nov 2007

GlaxoSmithKline obtains U.S. OTC marketing rights to MEVACOR (lovastatin) from Merck

GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).

27 Nov 2007

GlaxoSmithKline to acquire Reliant Pharmaceuticals

GlaxoSmithKline and Reliant Pharmaceuticals Inc. have announced that they had reached an agreement under which Reliant will be acquired by GSK for $1.65 billion (800 million pounds Sterling) in cash.

21 Nov 2007

Improving hospital safety rating tools

In a bid to clean up misleading institutional safety comparisons and go further to fix safety problems, Johns Hopkins experts are proposing standard guidelines to be used as hospital safety rating tools.

6 Nov 2007

Fenofibrate intervention and event lowering in diabetes

Fenofibrate is the first and only widely available lipid modifying agent to demonstrate significant protection to the eye of patients with type 2 diabetes, reducing the need for laser therapy in a wide spectrum of patients which should decrease the risk of progressive loss of vision.

6 Nov 2007

Link between statins and cognitive decline a complex one

Previous explorations of a link between statins, a cholesterol lowering medication, and cognitive decline have produced inconsistent results.

6 Nov 2007

Hypertension or atrial fibrillation linked to Alzheimer's disease progression

Alzheimer's disease (AD) may progress more rapidly in people with high blood pressure or a form of irregular heartbeat, atrial fibrillation, according to results of a Johns Hopkins study published in the Nov. 6, 2007, issue of Neurology.

6 Nov 2007

Half of heart attack patients stop taking lifesaving medications within three years

Recovery from heart attacks is best served by continuing to take prescribed medications.

6 Nov 2007

New investigational combination pill improves multiple cholesterol disorders

Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.

5 Nov 2007

Supplements do not reduce cancer risk

Most experts agree that supplements add little, if anything, to a well-balanced diet.

2 Nov 2007

Alzheimer's may progress more rapidly in people with high blood pressure or atrial fibrillation

While current medications for Alzheimer's disease are effective for some patients in slowing the rate of AD progression, many patients do not benefit from the treatments or cannot tolerate them, says lead researcher Michelle M. Mielke, Ph.D., of the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University School of Medicine.

31 Oct 2007

Do statins make radiation more effective at curing prostate cancer?

Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Children who are obese or who are at risk for obesity show early signs of heart disease

Childhood obesity in the United States is an epidemic -- nationwide, 19 percent of children ages 6 to 11 and 17 percent of those 12 to 19 are overweight, according to the Centers for Disease Control and Prevention (CDC). Those who are overweight during childhood also have an increased risk of obesity in adulthood and are at greater risk for complications such as diabetes, high blood pressure and heart disease, because obesity increases total blood volume, which leads to extra stress on the heart.

18 Oct 2007

Statins appear to preserve lung function

Statins are known to be good for lowering cholesterol and maybe even fighting dementia, and now they have another reported benefit: they appear to slow decline in lung function in the elderly - even in those who smoke.

15 Oct 2007